
|Videos|August 20, 2018
Treatment of Refractory Metastatic Renal Cell Carcinoma
Treatment of Refractory Metastatic Renal Cell Carcinoma
Advertisement
A 70-Year-Old African-American Woman with Metastatic RCC
December 2017
- A 70-year-old African-American woman presented to her PCP with loss of appetite, fatigue, abdominal pains, and blood in her stool
- CT of the chest, abdomen, & pelvis: distal esophageal thickening and appearance of a solid mass on the inferior pole of the right kidney (3.4 × 2.6 cm); well-defined hypodense nodules in the right lobe of the thyroid (2.1 × 2.8 cm) and bilateral adrenal glands
- Biopsy of renal mass revealed neoplastic cells with clear cytoplasm arranged in nests and mitotic figures suggesting clear cell carcinoma
- FNA from the thyroid nodule revealed neoplastic clear cells on cytology
- IHC; PAX8+, CAIX+, TTF-1(-)
- Diagnosis; right-sided renal cell carcinoma with clear cell histology; thyroid and bilateral adrenal metastasis (T4N0M1)
- She underwent right radical nephrectomy, right adrenalectomy, and radiofrequency ablation of left adrenal metastasis
- She was subsequently started on sunitinib and achieved a partial response within 3 months
June 2018
- Seven months later, the patient reports having increased fatigue
- MRI shows progression in both adrenal lesions
- Therapy was changed to lenvatinib plus everolimus
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































